USD 0.0
(0.0%)
Year | Inventory | Inventory Growth |
---|---|---|
2015 | 133 Thousand USD | 0.0% |
2014 | - USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
2011 | - USD | 0.0% |
2010 | - USD | 0.0% |
2009 | - USD | 0.0% |
2008 | - USD | 0.0% |
2007 | - USD | -100.0% |
2006 | 134.2 Thousand USD | -36.8% |
2005 | 212.35 Thousand USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2015 FY | 133 Thousand USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2013 Q2 | - USD | 0.0% |
2013 Q3 | - USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2012 Q2 | - USD | 0.0% |
2012 Q1 | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2012 Q3 | - USD | 0.0% |
2011 FY | - USD | 0.0% |
2011 Q4 | - USD | 0.0% |
2011 Q3 | - USD | 0.0% |
2011 Q2 | - USD | 0.0% |
2011 Q1 | - USD | 0.0% |
2010 FY | - USD | 0.0% |
2010 Q1 | - USD | 0.0% |
2010 Q2 | - USD | 0.0% |
2010 Q4 | - USD | 0.0% |
2010 Q3 | - USD | 0.0% |
2009 Q4 | - USD | 0.0% |
2009 FY | - USD | 0.0% |
2009 Q3 | - USD | 0.0% |
2009 Q2 | - USD | 0.0% |
2009 Q1 | - USD | 0.0% |
2008 Q1 | 507.65 Thousand USD | 0.0% |
2008 Q3 | - USD | 0.0% |
2008 Q4 | - USD | 0.0% |
2008 Q2 | - USD | -100.0% |
2008 FY | - USD | 0.0% |
2007 Q4 | - USD | -100.0% |
2007 Q2 | 554.44 Thousand USD | 53.09% |
2007 Q1 | 362.17 Thousand USD | 169.87% |
2007 FY | - USD | -100.0% |
2007 Q3 | 397.13 Thousand USD | -28.37% |
2006 FY | 134.2 Thousand USD | -36.8% |
2006 Q4 | 134.2 Thousand USD | -10.2% |
2006 Q3 | 149.45 Thousand USD | 0.0% |
2005 FY | 212.35 Thousand USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
American Bio Medica Corporation | 379 Thousand USD | 64.908% |
Arrayit Corporation | 464.19 Thousand USD | 71.348% |
Atlantic International Corp. | - USD | -Infinity% |
Biocept, Inc. | 757 Thousand USD | 82.431% |
Bioqual, Inc. | - USD | -Infinity% |
CardioGenics Holdings Inc | -2385.00 USD | 5676.52% |
DermTech, Inc. | 1 Million USD | 86.753% |
Global WholeHealth Partners Corporation | - USD | -Infinity% |
Hangzhou Tigermed Consulting Co., Ltd. | 3.29 Million USD | 95.969% |
HTG Molecular Diagnostics, Inc. | 909.32 Thousand USD | 85.374% |
iMD Companies, Inc. | 38.31 Thousand USD | -247.113% |
IDenta Corp. | 442.28 Thousand USD | 69.929% |
Interpace Biosciences, Inc. | 1.22 Million USD | 89.161% |
Integrative Health Technologies, Inc. | - USD | -Infinity% |
InVitro International | 163.13 Thousand USD | 18.472% |
Lumos Diagnostics Holdings Limited | 784 Thousand USD | 83.036% |
Many Bright Ideas Technologies Inc. | -375.00 USD | 35566.667% |
Medical Imaging Corp. | - USD | -Infinity% |
NovelStem International Corp. | - USD | -Infinity% |
Optigenex Inc. | 468.77 Thousand USD | 71.628% |
PharmChem, Inc. | 391.93 Thousand USD | 66.066% |
Proteome Sciences plc | 1.06 Million USD | 87.518% |
Rennova Health, Inc. | 242.64 Thousand USD | 45.187% |
RushNet, Inc. | - USD | -Infinity% |
ScreenPro Security Inc. | 73.89 Thousand USD | -79.98% |
Stella Diagnostics Inc. | - USD | -Infinity% |
StageZero Life Sciences Ltd. | 95.62 Thousand USD | -39.091% |
Todos Medical Ltd. | 1.02 Million USD | 86.974% |